Cytovale, a medical diagnostics company focused on developing technology that helps diagnose diseases, announced that it has scored $84 million in Series C funding, led by Norwest Venture Partners, with participation from other investors.
WHAT IT DOES
Cytovale offers its diagnostic test, IntelliSep, which received FDA 510(k) clearance last year. The test aims to assist in the early detection of...
